San Francisco, California, United States · Est. 2013
Theravance Biopharma is a biopharmaceutical company focused on developing and commercializing innovative medicines in respiratory and oncology therapeutic areas.
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Earlier
Details
Company Overview
—
Mkt Cap
$42.1M
Revenue
$37.8M
Cash
Therapeutic Focus
Recent SEC Filings
FORM 8-K
FORM 8-K
FORM 8-K
FORM 8-K
FORM 8-K
Regulatory
FORM 8-K
Accession: 0001104659-26-108980
FORM 8-K
Accession: 0001104659-26-106567
FORM 8-K
Accession: 0001104659-26-100860
FORM 8-K
Accession: 0001104659-26-093066
FORM 8-K
Accession: 0001104659-26-078453
FORM 8-K
Accession: 0001104659-26-076857
FORM 8-K
Accession: 0001104659-26-073559
Theravance Biopharma, Inc. (TBPH) (CIK 0001583107)
Accession: 001-36033
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)